This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Fredrik Tiberg, Ph.D.
President and CEO at Camurus AB


Fredrik Tiberg serves as President & CEO, Head of R&D, at Camurus (CAMX; NASDAQ STO) since 2003. Dr. Tiberg has spearheaded the development of the company’s proprietary FluidCrystal® technology platform as well as a broad late-stage pipeline of innovative investigational medical products, including global regulatory approvals of two products.

Dr. Tiberg received his MSc (Chemical Engineering) from Lund Institute of Technology, and his PhD in Physical Chemistry from Lund University. He was appointed professor in Surface Chemistry in 1999 and has held positions as adjunct and guest professor at Lund University until 2017. During 2001-2002 he was visiting professor at the Physical and Theoretical Chemistry Laboratory, Oxford University. Dr. Tiberg has over 120 peer-reviewed publications in Physical Chemistry, Biophysics, Material Science, Pharmaceutical and Clinical Research and is named inventor on more than 440 pending and granted patents. Dr. Tiberg is a member of the Royal Swedish Academy of Engineering Sciences (IVA).

Agenda Sessions

  • Novel Ready-to-use Long-acting Subcutaneous Somatostatin Analogue Formulations Based on In Situ Gelling Lipid Liquid Crystal